Dr Reddy's Laboratories Faces Share Price Drop Due to Semaglutide Supply Issues
Shares of Dr Reddy's Laboratories fell as much as 6.5% due to a delay in commercial supplies of semaglutide caused by an issue with the active pharmaceutical ingredient, impacting its performance and weighing on India’s pharmaceutical index.
Topics: drug supply issues generic drugs semaglutide stock price drop